AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UroGen Pharma Ltd. Director's Dealing 2023

Jul 28, 2023

Director's Dealing

Opens in your device viewer

Issuer: UroGen Pharma Ltd. (URGN)
CIK: 0001668243
Period of Report: 2023-07-25

Reporting Person: Robinson James A. Jr. (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-25	Stock Option (right to buy)	$8.84	A	20000	Acquired	2033-07-25	Ordinary Shares (20000)	Direct

F1: The shares underlying the stock option vest in equal quarterly installments over 12 months